Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
bluebird bio
AddedFeb 19, 2024
UpdatedJun 18, 2026
bluebird bio

bluebird bio

Public

Bluebird Bio, Inc.: A US-based biotech firm offering gene therapies for severe genetic disorders.

HQ
Cambridge, MA, US
Founded
1992
Overview
Compare
Fundraising
Employees
Website

Founded on April 16, 1992, by Philippe Leboulch and Irving London, Bluebird Bio, Inc. is a biotechnology company headquartered in Somerville, Massachusetts. The company's core mission is to develop curative gene therapies for severe genetic disorders, aiming to provide patients and their families with more "bluebird days." Bluebird Bio offers gene therapies for conditions such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders, beta-thalassemia, and sickle cell disease. Their market focus is primarily within the United States.

Notable figures affiliated with Bluebird Bio include President and CEO Andrew Obenshain and CFO Chris Krawtschuk. The company has achieved significant milestones, including FDA approval for their one-time gene therapy for sickle cell disease. Bluebird Bio's key products include Zynteglo, Skysona, and Lyfgenia. Despite financial challenges, including a net income loss of $819 million in 2021, the company continues to make impactful strides in the biotechnology and pharmaceutical industries.

bluebird bio - Similar Companies

Solid Biosciences logo

Solid Biosciences

solidbio.com

Regenxbio logo

Regenxbio

regenxbio.com

Biogen logo

Biogen

biogen.com

Generation Bio logo

Generation Bio

generationbio.com

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

Skylark Bio logo

Skylark Bio

skylarkbio.com

Krystal Biotech logo

Krystal Biotech

krystalbio.com

Editas Medicine logo

Editas Medicine

Voyager Therapeutics logo

Voyager Therapeutics

Sarepta Therapeutics logo

Sarepta Therapeutics

sarepta.com

Bluejay Therapeutics logo

Bluejay Therapeutics

bluejaytx.com

Jaguar Gene Therapy logo

Jaguar Gene Therapy

Caribou Biosciences logo

Caribou Biosciences

cariboubio.com

Blueprint Medicines logo

Blueprint Medicines

Excision BioTherapeutics logo

Excision BioTherapeutics

bluebird bio - Quick Facts

Who are bluebird bio's competitors?

Companies similar to bluebird bio include Solid Biosciences, Regenxbio, Biogen and Generation Bio.

When was bluebird bio founded?

bluebird bio was founded in 1992.

Where is bluebird bio's headquarters located?

bluebird bio's headquarters is located in Cambridge, MA, US.

When was bluebird bio's last funding round?

bluebird bio's most recent funding round was for $125M (USD) in December 2023.

How much has bluebird bio raised to-date?

As of Dec 19, 2023, bluebird bio has raised a total of $3.4B (USD).

How many employees does bluebird bio have?

bluebird bio has 323 employees as of Feb 6, 2024.

bluebird bio - Classification

Ownership
  • Public
Technology
  • Biotech
  • Gene Therapy
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Gene Therapies
Tags
  • Financial
  • Healthcare
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research